Authors: V Saraff, P Sancho, J Bacchetta, A M Boot, C Burren, AChinoy, P Dharmaraj, M A G Llorente, J D G Rodríguez, I Gueorguieva, E H Davies, W Hayes, S Komarzynski,...
The landscape of Health Technology Assessment (HTA) in Europe is evolving, particularly concerning advanced therapy medicinal products (ATMPs) and orphan medicinal products (OMPs) in oncology. The introduction of the EU HTA Regulation...
Authors: C L Simons, W-L Hwu, R Zhang, M J H G Simons, M Bergkvist, C Bennison Published: Advances in Therapy, 2023 View publication Introduction Aromatic L-amino acid decarboxylase (AADC) deficiency is...
In general, statistical modeling is used to explore factors such as patient mortality over time, quality of life and cost-effectiveness of a treatment to help various stakeholders make decisions. Modeling the long-term...
Authors: K M Bailey, N Sahota, U To & P Hedera Published: Orphanet Journal of Rare Diseases, 2023 View publication Background Wilson disease (WD) is a genetic disorder of copper metabolism that...
The following article summarizes important take-away messages from the Westminster Health Forum Policy Conference, which was held on April 28, 2023. The objective of the online meeting was to discuss priorities for...
Authors: E Fox, V Mehta, R Madhu3, E Wassmer, R Arora, T Cox, D Heaton, J Granerod & M Rance Published: International Journal of Rare Diseases & Disorders, 2022 View publication Background...
Authors: S Saberian, P Rowan, F Hammes, P Patel, F Fernandez-Cortes, K Buesch, I Beitia Ortiz de Zarate Published: Current medical research and opinion, 2022 View publication Background Aromatic L-amino acid decarboxylase...
Authors: H Schmidt, M W Cruz, M F Botteman, J A Carter, A Chopra, M Stewart, M Hopps, S Fallet, L Amass Published: Amyloid, 2017 View publication No abstract available